[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content
Download PDF

Automated classification of liver fibrosis stages using ultrasound imaging

BMC Medical Imaging volume 24, Article number: 36 (2024) Cite this article

Abstract

Background

Ultrasound imaging is the most frequently performed for the patients with chronic hepatitis or liver cirrhosis. However, ultrasound imaging is highly operator dependent and interpretation of ultrasound images is subjective, thus well-trained radiologist is required for evaluation. Automated classification of liver fibrosis could alleviate the shortage of skilled radiologist especially in low-to-middle income countries. The purposed of this study is to evaluate deep convolutional neural networks (DCNNs) for classifying the degree of liver fibrosis according to the METAVIR score using US images.

Methods

We used ultrasound (US) images from two tertiary university hospitals. A total of 7920 US images from 933 patients were used for training/validation of DCNNs. All patient were underwent liver biopsy or hepatectomy, and liver fibrosis was categorized based on pathology results using the METAVIR score. Five well-established DCNNs (VGGNet, ResNet, DenseNet, EfficientNet and ViT) was implemented to predict the METAVIR score. The performance of DCNNs for five-level (F0/F1/F2/F3/F4) classification was evaluated through area under the receiver operating characteristic curve (AUC) with 95% confidential interval, accuracy, sensitivity, specificity, positive and negative likelihood ratio.

Results

Similar mean AUC values were achieved for five models; VGGNet (0.96), ResNet (0.96), DenseNet (0.95), EfficientNet (0.96), and ViT (0.95). The same mean accuracy (0.94) and specificity values (0.96) were yielded for all models. In terms of sensitivity, EffcientNet achieved highest mean value (0.85) while the other models produced slightly lower values range from 0.82 to 0.84.

Conclusion

In this study, we demonstrated that DCNNs can classify the staging of liver fibrosis according to METAVIR score with high performance using conventional B-mode images. Among them, EfficientNET that have fewer parameters and computation cost produced highest performance. From the results, we believe that DCNNs based classification of liver fibrosis may allow fast and accurate diagnosis of liver fibrosis without needs of additional equipment for add-on test and may be powerful tool for supporting radiologists in clinical practice.

Peer Review reports

Introduction

Damage of hepatocytes caused by various etiologies such as infection, non-alcoholic fatty liver, alcohol, inherited metabolic disease, immune disease, and drug induces activation of hepatic stellate cell, secretion of cytokines and accumulation of collagens, resulting in liver fibrosis [1]. Cirrhosis is the most severe and irreversible stage of liver fibrosis, which can progress to portal hypertension and hepatocellular carcinoma [2]. Thus, accurate diagnosis of liver fibrosis in early stage is of great importance in clinical practice since prognosis and management of chronic liver diseases are related to severity of liver fibrosis.

The histopathological examination through liver biopsy is the gold standard for liver fibrosis diagnosis and staging. However, liver biopsy is prone to sampling errors due to examination of small liver parenchyma specimen, and to intra-/inter-observer variations [3, 4]. In addition, it is invasive that can cause various complications and may lead to death. Thus, repeated liver biopsy to trace disease progression is not recommended.

To overcome these limitation, non-invasive methods such as magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound (US) imaging for accessing liver fibrosis have been investigated and shown promising results despite the need for additional time and equipment [5,6,7]. These imaging modalities provide not only morphological information (e.g., parenchymal changes and portal hypertension) but also functional information (e.g., stiffness of tissue) that is related to the stage of fibrosis. Among these, US imaging is the widely available modality with no ionizing radiation. Thus, US imaging is the most frequently performed in the regular follow-up of patients with chronic hepatitis or liver cirrhosis for the detection of hepatocellular carcinoma and an evaluation of the degree of liver fibrosis. It was reported that the progression of fibrosis include alteration of parenchymal echogenicity (graded as fine echotexture, mildly coarse and highly coarse) and surface nodularity [8]. Figure 1 shows the representative US images of liver fibrosis for each stage. Although these imaging findings have a correlation with the degree of liver fibrosis, interpreting the findings is subjective thus well-trained radiologist is required for evaluation.

Fig. 1
figure 1

Representative US images of liver fibrosis. Alteration of parenchymal echogenicity (graded as fine echotexture, mildly coarse and highly coarse) and surface nodularity can be identified as the liver fibrosis progress

Full size image

Recently, several studies have shown that deep convolutional neural networks (DCNNs) based diagnosis and assessment of liver fibrosis is viable solution using MR and CT images [9,10,11,12,13]. A DCNN-based quaternary classification model was developed to classify liver cirrhosis (F0/F1/F23/F4) using US B-mode images [14]. In the method, VGGNet was applied for transfer learning and the accuracy of VGGNet for METAVIR score classification was 83.5%. However, the developed automated classification model was trained using images obtained by US machines from three major vendors (i.e., GE healthcare, Philips Medical Systems and Siemens Medical Solution). Because the model learned from images acquired from a limited domain would be biased toward the characteristic of the corresponding machine, it may achieve a weak performance when applying US images acquired from another domain. Considering that there are many different types of US machines, multi-domain data are necessary to reflect real clinical situations.

The purpose of this study was to access the performances of popular and well-established DCNNs (VGGNet, ResNet, DenseNet, EfficientNet and ViT) to identify that which of DCNNs trained on the ImageNet dataset will perform best for the classification of liver fibrosis using US images obtained from 11 different US machine.

Related works

In this section, we describe previous works on US image classification using deep learning. It was reported that an accuracy of 90.6% in identifying fatty liver disease from US images could be achieved by using the VGG-16 model [15]. A novel multi-task learning approach for segmenting and classifying tumors in breast ultrasound images was proposed [16]. In the method, they used VNet as the backbone network. The proposed network comprised an encoder-decoder network for segmentation and a lightweight multi-scale network was integrated for classification. A regularized spatial transformer network was proposed for automated pleural effusion detection in lung US and an accuracy of 91.12% was achieved in classification of pleural effusion [17]. The performance of ResNet pre-trained with the ImageNet dataset for classification of chronic liver disease in renal US imaging was evaluated [18]. For classifying thyroid nodules and breast lesions in US images, TNet and BNet using pre-trained VGG-19 was developed and could achieve classification accuracies of 86.3% and 86.5%, repectively [19]. A deep learning architecture that includes a feature extraction network, an attention-based feature aggregation network, and a classification network was also proposed for diagnosing thyroid nodules [20].

Materials and methods

Ethics committee approval

US images from two tertiary university hospitals (Seoul St. Mary’s Hospital, The Catholic University of Korea and Eunpyeong St. Mary’s Hospital, The Catholic University of Korea) were used for the training and validation. This study was approved by the institutional review boards of both hospitals (Seoul St. Mary’s Hospital: KC20RISI0869 and Eunpyeong St. Mary’s Hospital: PC20RISI0229). The requirement for informed consent was waived because of the retrospective study design.

Training and validation dataset

Table 1 summarizes the clinical characteristics of the 933 patients (556 male patients) included in this study. The median age was 54 years old (interquartile range, 44–63). The numbers of patients and images that were used in this study were summarized according to US machines in Table 2. Only patients who underwent liver biopsy or hepatectomy between 2011 and 2020 at the Seoul St. Mary’s Hospital, or between 2019 and 2020 at the Eunpyeong St. Mary’s Hospital, were eligible for this study. Although non-invasive methods such as transient elastography are widely used to evaluate liver fibrosis, there is a possibility that errors will occur in cases of a contracted liver or ascites. Among them, patients who underwent a liver US within 3 months prior to biopsy or surgery were included in this study, with 745 patients from the Seoul St. Mary’s Hospital and 188 patients from the Eunpyeong St. Mary’s Hospital in the training/validation. A radiologist with 11 years of experience with abdominal US reviewed all images and selected liver images regardless of scanning plane. All images obtained with using a convex probe. In this study, for the automated diagnosis of liver fibrosis, we categorized liver fibrosis based on pathology results of biopsy or hepatectomy using the METAVIR score [21]. Note that a pathology report is a medical document that provides final diagnosis based on microscopic examination of the tissue specimen. The METAVIR score consists of five classes, i.e., F0, F1, F2, F3, and F4. Here, F0 indicates no fibrosis; F1, portal fibrosis without septa and an insignificant abnormal area; F2, portal fibrosis with few septa and abnormalities in an area wider than with F1; F3, numerous septa without cirrhosis and prominent abnormalities; and F4, cirrhosis. We experimented with a five-level classification of F0, F1, F2, F3, and F4 for liver fibrosis.

Table 1 The characteristics of patients in the data
Full size table
Table 2 Distribution of liver fibrosis stages in the training and validation data
Full size table

Data preprocessing

The distribution of the grades of liver fibrosis is shown in Table 1. Training and validation data were used at a ratio of 8:2 for the entire dataset. Before training a model, the distribution ratio of the dataset must be considered. In particular, data on diseases that are difficult to detect in early stage, such as liver fibrosis, have an imbalance in terms of degree. In general, F0 is easily obtained, and such data occupy 28.1% of the dataset. F4, the end stage of liver fibrosis, accounted for 33.2% of the dataset. However, the proportions of F1 (13.3%), F2 (11.0%), and F3 (14.4%) were relatively small because only a few patients were examined during the early stages of liver fibrosis. Such data imbalance can bias and overfit the model training [22, 23]. To solve this problem, data augmentation should be conducted [24]. Using a computer vision method, a data augmentation of the images expands the size of a limited dataset. In general, flipping, color jitter, cropping, rotation, translation, and noise generation are used for such augmentation [25]. However, data augmentation may undermine the inherent meaning of the original data depending on the augmentation method applied. Since the US images using a convex array are fan shape, horizontal flips were only applied for data augmentation in this work. The final images were normalized and resized to a pixel resolution of 224 × 224 for model training. The size of input images should be adjusted appropriately to align with the dimensions permitted by the DCNN models. The approved input size for the key models used in our experiments is 224 × 224, and it is recommended to maintain a standardized resolution for objective experimentation. Furthermore, we employ transfer learning using pre-trained parameters from ImageNet. To optimize the effectiveness of transfer learning, it is crucial to minimize alterations to the model.

Implementation of DCNNs

The models were trained using VGGNet-16, ResNet-50, DenseNet-121, EfficientNet-B0, and ViT [26,27,28,29,30]. Each model commonly consists of an encoder fθ and a classifier gθ. The encoder fθ extracts mid-level features through a convolution, and the classifier gθ is a linear classifier that classifies the final features. The encoder fθ follows the architectures of the VGG, ResNet, DenseNet, EfficientNet, and ViT models. Notably, each model exhibits distinctive implementation features. VGG is characterized by its simplicity and uniformity. With 16 weight layers, VGG employs small 3 × 3 convolutional filters and max-pooling layers. ResNet utilizes residual blocks with skip connections, addressing the vanishing gradient problem by enabling the flow of gradients through the network. DenseNet redefines connectivity in neural networks. DenseNet’s dense blocks connect all layers by concatenating feature maps, promoting maximal information flow. EfficientNet excels in balancing model depth, width, and resolution. Its compound scaling method adjusts these dimensions simultaneously, achieving state-of-the-art performance with a smaller model. EfficientNet represents an innovative approach to optimizing computational efficiency. ViT (Vision Transformer) introduced the transformer architecture to computer vision. Departing from traditional convolutional structures, ViT tokenizes input images into patches and employs self-attention mechanisms. This pioneering approach allows ViT to capture global dependencies effectively, achieving performance comparable to or surpassing traditional convolutional models at a fraction of the computational cost.

The final classifier g is implemented as a fully-connected layer, constituting a linear classifier. The output value of g is normalized to a probability using the softmax function. The objective cross-entropy function is configured such that the probability of the target class is maximized. Finally, the parameter θ is trained to optimize the objective function.

We applied transfer learning for model training (Fig. 2) because scratch learning is valid when the number of training data is more than 5000 per class [31, 32]. Transfer learning uses a model trained on an extensive dataset from another domain. In general, the ImageNet dataset, which consists of 1000 classes, is widely used for pre-training. Model training using extensive datasets is suitable for extracting meaningful features from input images. Because the pre-trained model has been trained to find high-level features, the convolution filter of the model is better optimized than scratch learning when learning a new domain from the pre-training. If the pre-trained and post-trained datasets are in similar domains, the models can yield valid results even when freezing the convolution layers. However, in post-training using medical images, the model must be retrained based on the overall parameters because ImageNet and medical images have different cardinal features. In this study, after transfer learning on ImageNet, we conducted fine-tuned the model using US images [33].

Fig. 2
figure 2

Training diagram of DCNNs. Five models (VGG16, ResNet50, DenseNet121, EfficientNet-B7, and ViT) were trained using US images from 11 different machines. The number of data is based on patients. DCNN, deep convolutional neural network; US, ultrasound

Full size image

In this study, the loss function for model training was CrossEntropyLoss by Negative Loglikelihood, and the optimization algorithm and learning-rate scheduler were the Adam optimizer and CosineAnnealingLR, respectively. The initial learning rate started at 0.0001 and was adjusted to a value close to zero every 50th epoch by the scheduler. We trained the model for 1000 epochs using a batch size of 64.

Evaluation metrics

The performance of DCNNs was evaluated through accuracy, sensitivity, specificity, positive and negative likelihood ratio. In addition, area under the receiver operating characteristic curve (AUC) with 95% confidential interval for five-level (F0/F1/F2/F3/F4) classification was used to assess the efficiency of DCNNs.

Results

Table 3 summarizes the diagnostic performance of DCNNs for five-level classification. Similar AUC values were achieved for five models (Fig. 3); VGGNet (mean: 0.96, range: 0.94–0.98), ResNet (0.96, 0.93–0.97), DenseNet (0.95, 0.94–0.96), EfficientNet (0.96, 0.94–0.97), and ViT (0.95, 0.94–0.97). The same mean accuracy value (0.94) was yielded for all models. In terms of sensitivity, EffcientNet achieved highest value (0.85, 0.80–0.89) while the other models produced slightly lower values; VGGNet (0.82, 0.72–0.89), ResNet (0.84, 0.75–0.90), DenseNet (0.82, 0.75–0.89), and ViT (0.83, 0.76–0.92). All model achieved approximately the same mean specificity value (0.96).

Table 3 Diagnostic performance of DCNNs for five-level classification
Full size table
Fig. 3
figure 3

Receive operation characteristic curves with 95% confidence intervals for classification of liver fibrosis according to METAVIR score using VGGNet, ResNet, DenseNet, EfficientNet and ViT, respectively

Full size image

Discussion

In this study, we demonstrated that DCNNs trained by transfer learning on ImageNet can classify the staging of liver fibrosis according to METAVIR score with high performance (AUC: > 0.95, accuracy: 0.94) using conventional B-mode images from multiple US machines. Five different DCNNs showed good diagnostic performance, and the highest performance was achieved with comparably less computational complex network, i.e., EfficientNET.

Recently, various studies have been conducted on DCNN-based automatic detection and classification using US images [34]. Automated staging of liver fibrosis based on US images was also investigated [14]. Although high performance (AUC: 0.90, accuracy: 0.94) was achieved for classification of significant fibrosis (F2 or greater), the accuracy for quadrant classification (F0/F1/F23/F4) was relatively low (0.83). This is mainly due to the imbalance of training dataset. In our method, we conducted data augmentation to balance data distribution, which prevent bias and overfit the model training. In addition, our result showed that computational complex networks do not always guarantee better performance. The use of DCNNs with less computations have several advantage since it can lower hardware complexity and reduce training time. This will allow fast and easy implementation of DCNNs for automated classification on conventional US machines.

US is commonly used to evaluate the liver in patients with chronic liver disease. Liver fibrosis stage is difficult to predict solely based on US B-mode images even with regular follow-up because the morphology or echogenicity of the liver does not change remarkably in the early stage of liver fibrosis. Therefore, US elastography has been used as a promising imaging technique to evaluate the elastic modulus of tissues and to evaluate liver fibrosis [35,36,37]. However, liver fibrosis stage was divided into two groups, such as F4 versus others, in most studies since it is still difficult to classify five stages of liver fibrosis even with elastography. Once our approach is mounted on existing machines, it will be a convenient alternative tool for assessing liver fibrosis without selection of scanning plane and needs of additional equipment for add-on test such as Fibroscan and elastography, especially in low-to-middle income countries.

In this work, we compared the results of the main backbone models ranging from shallow to deep networks. While various state-of-the-art (SOTA) models exist, the majority of them adopt derivative structures from our experimental models. Therefore, for an objective assessment of the effectiveness of DCNN, it is appropriate to evaluate the performance using the fundamental forms that constitute the backbone, including the latest baseline such as Vit.

Our study has several limitations. First, since we used the data augmentation to balance the dataset for each stage, it could undermine the performance of networks. For our approach to be used in practice, the model should be trained using sufficiently large dataset (more than 5000 case for each stage) without data augmentation. Second, although we included as many US machines (11 different machines) as possible, there are dozens of companies that manufacture US scanners. Since all manufacturers have their own image processing methods such as filtering and speckle reduction, echotexture or feature of images is different from each other (see Fig. 1). For versatile solution, we may need to include images from every US machines for training. Otherwise, model need to be trained individually by using images from each US machine. Third, the US images used for training were acquired by well-trained radiologists. Considering that US is highly operator-dependent, images from under-trained radiologists may need to be included for low-to-middle income countries with weak health care systems. Fourth, due to the computational burden, we resized images to 224 × 224 for model training, thus our approach may use the overall morphological features such as liver surface irregularity to classify liver fibrosis. The alteration of parenchymal echogenicity also convey useful information to predict liver fibrosis [8]. Thus, if we can use whole B-mode image without sacrificing the resolution, the performance of model could be improved. Finally, due to the nature of retrospective study, we could not include information regarding hepatitis B or C and alcohol consumption. However, liver fibrosis is diagnosed regardless of the cause, thus absence of etiology would not undermine our experiment results.

In conclusion, we have demonstrated that DCNNs can classify METAVIR score using conventional US images with high accuracy. Given the fact that US imaging is widely available modality and the most frequently used in the regular follow-up of patient with chronic liver disease, DCNNs based classification of liver fibrosis using B-mode images will be powerful tool for supporting radiologists in clinical practice, which however need further improvement and validation would be required.

Data availability

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

References

  1. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol. 1999;5:301–4.

    Article  PubMed  PubMed Central  Google Scholar 

  4. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15–20.

    Article  Google Scholar 

  5. Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009;252:595–604.

    Article  PubMed  Google Scholar 

  6. Yoon JH, Lee JM, Klotz E, et al. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading. Invest Radiol. 2015;50:290–6.

    Article  PubMed  Google Scholar 

  7. Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY). 2020;45:3444–62.

    Article  PubMed  Google Scholar 

  8. Nishiura T, Watanabe H, Ito M, et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol. 2005;78:189–97.

    Article  CAS  PubMed  Google Scholar 

  9. Choi KJ, Jang JK, Lee SS, et al. Development and validation of a deep learning system for staging liver fibrosis by using contrast agent-enhanced CT images in the liver. Radiology. 2018;289:688–97.

    Article  PubMed  Google Scholar 

  10. Yasaka K, Akai H, Kunimatsu A, Abe O, Kiryu S. Deep learning for staging liver fibrosis on CT: a pilot study. Eur Radiol. 2018;28:4578–85.

    Article  PubMed  Google Scholar 

  11. Hectors SJ, Kennedy P, Huang KH, Stocker D, Carbonell G, Greenspan H, Friedman S, Taouli B. Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI. Eur Radiol. 2021;31:3805–14.

    Article  CAS  PubMed  Google Scholar 

  12. Kim YH. Artificial intelligence in medical ultrasonography: driving on an unpaved road. Ultrasonography. 2021;40:313–7.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Storelli L, Azzimonti M, Gueye M. A Deep Learning Approach to Predicting Disease Progression in multiple sclerosis using magnetic resonance imaging. Invest Radiol. 2022;57:423–32.

    Article  PubMed  Google Scholar 

  14. Lee JH, Joo I, Kang TW, et al. Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network. Eur Radiol. 2020;30:1264–73.

    Article  PubMed  Google Scholar 

  15. Reddy DS, Bharath R, Rajalakshmi P. ‘A novel computeraided diagnosis framework using deep learning for classification of fatty liver disease in ultrasound imaging. Proc. IEEE 20th Int Conf e-Health Netw, Appl. Services (Healthcom) 2018; 1–5.

  16. Zhou Y, Chen H, Li Y, et al. Multi-task learning for segmentation and classification of tumors in 3d automated breast ultrasound images. Med Image Anal. 2021;70:101918.

    Article  PubMed  Google Scholar 

  17. Tsai CH. Automatic deep learning-based pleural effusion classification in lung ultrasound images for respiratory pathology diagnosis. Phys Medica. 2021;83:38–45. 2021.

  18. Kuo CC, Chang CM, Liu KT, et al. Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learning. NPJ Digit Med. 2019;2:29.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zhu YC, AlZoubi A, Jassim S, et al. A generic deep learning framework to classify thyroid and breast lesions in ultrasound images. Ultrasonics. 2021;110:106300.

    Article  PubMed  Google Scholar 

  20. Wang L, Zhang L, Zhu M, Qi X, Yi Z. Automatic diagnosis for thyroid nodules in ultrasound images by deep neural networks. Med Image Anal. 2020;61:101665.

    Article  PubMed  Google Scholar 

  21. Panel CPG, Berzigotti A, Tsochatzis E, et al. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update. J Hepatol. 2021;75:659–89.

    Article  Google Scholar 

  22. Thabtah F, Hammoud S, Kamalov F, Gonsalves A. Data imbalance in classification: experimental evaluation. Inf Sci. 2020;513:429–41.

    Article  MathSciNet  Google Scholar 

  23. Johnson JM, Khoshgoftaar TM. Survey on deep learning with class imbalance. J of Big Data. 2019;6:1–54.

    Article  Google Scholar 

  24. Shorten C, Khoshgoftaar TM. A survey on image data augmentation for deep learning. J of big data. 2019;6:1–48.

    Article  Google Scholar 

  25. Parmar N, Vaswani A, Uszkoreit J, et al. Image transformer. Int Conf Mach Learn. 2018;PMLR 2018:4055–64.

    Google Scholar 

  26. Simonyan K, Zisserman A. Very deep convolutional networks for large-scale image recognition. arXiv:1409.1556 2014.

  27. He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. Proceedings of the IEEE conference on computer vision and pattern recognition. 2016;770–778.

  28. Huang G, Liu Z, Van Der Maaten L, Weinberger KQ. Densely connected convolutional networks. Proc IEEE Conf Comput Vis Pattern Recognit. 2017;4700:4708.

    Google Scholar 

  29. Tan M, Le Q, Efficientnet. Rethinking model scaling for convolutional neural networks. in: International conference on machine learning, PMLR 2019;6105–6114.

  30. Dosovitskiy A, Beyer L, Kolesnikov A et al. An image is worth 16x16 words: Transformers for image recognition at scale. arXiv:2010.11929 2020.

  31. Weiss K, Khoshgoftaar TM, Wang D. A survey of transfer learning. J of Big data 2016:31–40.

  32. Shaha M, Pawar M. Transfer learning for image classification. 2018 Second International Conference on Electronics Communication and Aerospace Technology IEEE. 2018;656:660.

    Google Scholar 

  33. Tajbakhsh N, Shin JY, Gurudu SR, et al. Convolutional neural networks for medical image analysis: full training or fine tuning? IEEE Trans med Imaging. 2016;35:1299–312.

    Article  PubMed  Google Scholar 

  34. Cao Z, Duan L, Yang G, Yue T, Chen Q. An experimental study on breast lesion detection and classification from ultrasound images using deep learning architectures. BMC med Imaging. 2019;19:1–9.

    Article  Google Scholar 

  35. Jeong WK, Lim HK, Lee H, Jo JM, Kim Y. Principles and clinical application of ultrasound elastography for diffuse liver disease. Ultrasonography. 2014;33:149–60.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lee DH, Lee ES, Lee JY, et al. Two-dimensional-shear Wave Elastography with a propagation map: prospective evaluation of liver fibrosis using histopathology as the Reference Standard. Korean J Radiol. 2020;21:1317–25.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Herrmann E, Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67:260–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research has been supported in part by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (NTIS Number: 9991007146), in part by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI21C0940110021), and in part by the Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No. 2022-0-00101, Development of an intelligent HIFU therapy system using highly functional real-time image guide and therapeutic effect monitoring based on ICT fusion ).

Author information

Authors and Affiliations

  1. Division of Industrial Mathematics, National Institute for Mathematical Sciences, 70, Yuseong-daero, Yuseong-gu, 34047, Daejeon, Republic of Korea

    Hyun-Cheol Park

  2. Department of Computer Engineering, Gachon University, 1342, Seongnam-daero, Sujeong-gu, 13120, Seongnam-si, Gyeonggi-do, Republic of Korea

    YunSang Joo & Chang Choi

  3. Department of Artificial Intelligence, The Catholic University of Korea, 43, Jibong-ro, 14662, Bucheon-si, Gyeonggi-do, Republic of Korea

    O-Joun Lee

  4. Department of Electronic Engineering, Sogang University, 35 Baekbeom-ro, 04107, Seoul, Republic of Korea

    Kunkyu Lee & Tai-Kyong Song

  5. Department of Radiology, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seoul, Republic of Korea

    Moon Hyung Choi

  6. Department of Biomedical Engineering, Department of Nanoscience and Engineering, Inje University, Inje-ro 197, 50834, Gimhae, Gyeongnam, Republic of Korea

    Changhan Yoon

Authors
  1. Hyun-Cheol Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. YunSang Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O-Joun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kunkyu Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tai-Kyong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chang Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Moon Hyung Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Changhan Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

OL, CC, KL and TS: Critical revision of the manuscript. HP, KL and YJ: Data analysis or interpretation, Drafting of the manuscript. MC and CY: Conception, Data acquisition, Critical revision of the manuscript. All authors: Approval of the final version of the manuscript.

Corresponding authors

Correspondence to Moon Hyung Choi or Changhan Yoon.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the institutional review boards of both hospitals (Seoul St. Mary’s Hospital, The Catholic University of Korea: KC20RISI0869 and Eunpyeong St. Mary’s Hospital, The Catholic University of Korea: PC20RISI0229). All methods were performed in accordance with the relevant guidelines and regulations. The requirement for informed consent was waived because of the retrospective study design (Seoul St. Mary’s Hospital, and Eunpyeong St. Mary’s Hospital).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, HC., Joo, Y., Lee, OJ. et al. Automated classification of liver fibrosis stages using ultrasound imaging. BMC Med Imaging 24, 36 (2024). https://doi.org/10.1186/s12880-024-01209-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12880-024-01209-4

Keywords

BMC Medical Imaging

ISSN: 1471-2342

Contact us